PHARMACYTE BIOTECH, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for the quarter ending 2022-07-31 was $2.28K, a 90.80% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for the quarter ending 2022-01-31 was $2.44K, a 54.85% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for the quarter ending 2021-10-31 was $4.57K, a 76.17% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for the quarter ending 2021-07-31 was $24.77K, a 38.93% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for fiscal 2023 was $2.28K, a 93.46% decline from fiscal 2022.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for fiscal 2022 was $34.85K, a 50.45% decline from fiscal 2021.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for fiscal 2021 was $70.33K, a 85.14% decline from fiscal 2020.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, issued for services for fiscal 2020 was $473.14K, a 49.47% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-04-30 | $2.28K 10-K · filed 2024-08-13 | |
| 2022-07-31 | $2.28K 10-Q · filed 2024-03-18 | |
| 2022-04-30 | $34.85K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $2.44K 10-Q · filed 2023-03-16 | |
| 2021-10-31 | $4.57K 10-Q · filed 2023-03-16 | |
| 2021-07-31 | $24.77K 10-Q · filed 2023-03-16 | |
| 2021-04-30 | $70.33K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $5.41K 10-Q · filed 2022-03-15 | |
| 2020-10-31 | $19.16K 10-Q · filed 2022-03-15 | |
| 2020-07-31 | $40.55K 10-Q · filed 2022-03-15 | |
| 2020-04-30 | $473.14K 10-K · filed 2021-08-10 | |
| 2020-01-31 | $26.09K 10-Q · filed 2021-03-12 | |
| 2019-10-31 | $73.55K 10-Q · filed 2021-03-12 | |
| 2019-07-31 | $311.82K 10-Q · filed 2021-03-12 | |
| 2019-04-30 | $316.54K 10-K · filed 2020-08-13 | |
| 2019-01-31 | $35.43K 10-Q · filed 2020-03-13 | |
| 2018-10-31 | $59.65K 10-Q · filed 2020-03-13 | |
| 2018-07-31 | $45.80K 10-Q · filed 2020-03-13 | |
| 2018-04-30 | $309.88K 10-K · filed 2019-08-13 | |
| 2018-01-31 | $69.84K 10-Q · filed 2019-03-14 | |
| 2017-10-31 | $86.45K 10-Q · filed 2019-03-14 | |
| 2017-07-31 | $94.49K 10-Q · filed 2019-03-14 | |
| 2017-04-30 | $107.50K 10-K · filed 2018-07-20 | |
| 2016-04-30 | $48.00K 10-K · filed 2017-07-27 | |
| 2015-04-30 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $1.27M 10-K · filed 2016-07-29 |
| 2015-01-31 | -$367.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | $4.31M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $3.64M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-07-31 | -$297.50K 10-Q · filed 2014-09-15 | $4.73M derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-04-30 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $3.83M 10-K · filed 2016-07-29 |
| 2014-01-31 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | -$186.00K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-10-31 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $72.40K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-07-31 | -$1.20M 10-Q · filed 2014-09-15 | |
| 2013-04-30 | $966.40K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $331.00K 10-K/A · filed 2016-01-19 |
| 2013-01-31 | -$782.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | |
| 2012-04-30 | $409.40K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |